$100M Early-Stage Venture Capital Limited Partnership Fund

We go beyond just investing; we fund the technology to benefit people and the planet. Billions of dollars are spent on research that never makes it to market. This is our hunting ground.

Grey Innovation Investment Partners

Authorised representative 1283807 of Australian Financial Services License 334 906

Grey Innovation Investment Partners is currently raising funds for a first close.

Decreasing the traditional risk of the ESVCLP model, Grey Innovation Investment Partners, is investing in sophisticated early-stage companies. Although working independent of Grey Innovation Group, the fund has first market access to Grey Innovation Group's suite of portfolio companies in, or approaching, early-stage revenue, significantly reducing the risk.

Now is our time to make an impact


An ESG Impact Fund

We strive for a positive ESG impact alongside strong financial returns.

The future of Environmental, Social and Governance (ESG) lies in the commercialisation of technology that focuses on responsible and sustainable operations and outputs. Grey Innovation Investment Partners seeks to invest in early-stage technology that improves lives and benefits the planet.

Strict ESG mandates and policies underlining the Fund are critical for thorough risk analysis and decreasing overall portfolio risk. We consider ESG risks and opportunities throughout every step of the investment process and apply our strict responsible investing principles to all investments within the Fund.


UN Principles of Responsible Investment signatory

Grey Innovation Investment Partners commits to ESG transparency and accountability. The PRI is a set of six voluntary and aspirational principles for incorporating and reporting on ESG throughout the investment process. Grey Innovation Investment Partners has committed to abide by and report on the UN Principles of Responsible Investment.

 

Logo PRI Signatory


Downloads

INFORMATION MEMORANDUM

PRESENTATION

The Structure

Investors

Limited Partners

Manager

Grey Innovation Investment Partners PTY LTD

 

  • Management team track record of delivering > 20% internal rate of return for investors
  • Full access to all Grey Innovation Group resources
  • 43.5% R&D cash rebate for Fund

Fees

  • Management fee: 1.5% (years 1-5) 1% of invested capital (less investments written down to zero) thereafter
  • 8% preferred return
  • 20% carry
  • Establishment fee (up to $300k)

The Fund

Grey Innovation Ventures I, LP
Authorised representative 1283807 of Australian Financial Services License 334 906

  • No capital gains tax
  • Projected internal rate of return > 20%
  • Immediate 10% write off
  • Size $100M
  • Term 10 Years (with potential to extend by 3 years)

Portfolio Companies

 

  • Up to 13 investments of ~$7-10M each
  • Targeted sectors: Cleantech, Medtech
  • Australian private company deal flow

First market access to Grey Innovation Group portfolio companies in or approaching early revenue with:

  • unique skills base, repeatable start-up processors
  • discounted product development and commercialisation
  • proven track record
  • discounted service fees and license fees
  • access to a first class international network
Eco Detection Firefly Greyscan Track Alert Systems Canopy Blue

People

Investment Partners

All Board Executive Investment Committee

Organisational Chart

org chart

Now is our time

Unprecedented funding aligns with our portfolio mandate.

$1.9 billion

Australian Renewable Energy Agency (ARENA) and Clean Energy Finance Corporation (CEFC) to fund low emission technologies.

$300 million

Advancing Hydrogen Fund (Federal Government) (run by the CEFC)

$1.3 billion

The Manufacturing Translation and Integration Streams aims to help manufacturers translate good ideas into commercial outcomes. This forms part of the Modern Manufacturing Initiative (MMI).

$20 billion

Medical Research Future Fund (Federal Government)

Plus, many more millions in ongoing grants for Cleantech and Medtech.

R&D Tax Incentive – 43.5% credits on research and development.

Partners

Research Institute Global & Channel Partners

Department of the Prime Minister and Cabinet
Royal Eye and Ear Hospital
UTAS
DZNE
St Vincents Hospital
University of Melbourne
Charles Sturt University
Cochlear
Peter Mac
ResMed
Smiths
Eastern Health
Bosch
PMHC
HP Invent
Monash Vision Group
Siemens
Swinbourne
Global Kinetics
Intel
Nanosonics
National Health and Medical Research Council
The Alfred Hospital
Monash University
IBM
Australian Research Council
State Government of Victoria
Fraunhofer
TMS
Australian National University
Telstra Eureka